Reilly Financial Advisors’s Abiomed Inc ABMD Stock Holding History

Reilly Financial Advisors’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$6K	Buy	+18	New	+$6.08K	﹤0.01%	816
2021 Q3	–	Sell	-51	Closed	-$16K	–	1099
2021 Q2	$16K	Hold	51	–	–	﹤0.01%	605
2021 Q1	$16K	Hold	51	–	–	﹤0.01%	595
2020 Q4	$17K	Hold	51	–	–	﹤0.01%	529
2020 Q3	$14K	Hold	51	–	–	﹤0.01%	517
2020 Q2	$12K	Hold	51	–	–	﹤0.01%	546
2020 Q1	$7K	Sell	51 -50	-50%	-$8.3K	﹤0.01%	630
2019 Q4	$17K	Hold	101	–	–	﹤0.01%	542
2019 Q3	$18K	Hold	101	–	–	﹤0.01%	539
2019 Q2	$26K	Hold	101	–	–	﹤0.01%	480
2019 Q1	$29K	Hold	101	–	–	﹤0.01%	443
2018 Q4	$33K	Hold	101	–	–	﹤0.01%	402
2018 Q3	$45K	Hold	101	–	–	0.01%	384
2018 Q2	$41K	Hold	101	–	–	0.01%	348
2018 Q1	$29K	Buy	101 +50	+98%	+$12.7K	﹤0.01%	397
2017 Q4	$10K	Hold	51	–	–	﹤0.01%	663
2017 Q3	$9K	Hold	51	–	–	﹤0.01%	665
2017 Q2	$7K	Hold	51	–	–	﹤0.01%	729
2017 Q1	$6K	Buy	+51	New	+$5.91K	﹤0.01%	717

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Reilly Financial Advisors's ABMD Position: Q4 2021 in Review

Reilly Financial Advisors opened a new position in Abiomed Inc (ABMD) in Q4 2021: 18 shares worth $6K. The stake represents ﹤0.01% of the portfolio and ranks #816 among its holdings. This is a return to the name: Reilly Financial Advisors previously reported a position in ABMD as recently as Q2 2021.

Reilly Financial Advisors first reported a position in ABMD in Q1 2017 and has held it in 19 quarters since. The position peaked at $45K in Q3 2018. 496 funds tracked by Wall St. Rank hold ABMD as of Q4 2021.

Reilly Financial Advisors held 18 shares of Abiomed Inc worth $6K as of Q4 2021.
Abiomed Inc was a new Reilly Financial Advisors position in Q4 2021.
Abiomed Inc made up ﹤0.01% of Reilly Financial Advisors's portfolio in Q4 2021, its #816 holding.
Reilly Financial Advisors first reported a position in Abiomed Inc in Q1 2017 and has held it in 19 quarters since.
Reilly Financial Advisors's Abiomed Inc position peaked at $45K in Q3 2018.
496 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2021.

Based on Reilly Financial Advisors's 13F filing for Q4 2021, filed 25 Jan 2022.